Literature DB >> 33682063

Longitudinal Changes in Exercise Capacity in Patients Who Underwent Ross Procedure and Mechanical Aortic Valve Replacement: Does the Type of Surgery Matter?

Daiji Takajo1, Vasudha Kota2, Preetha P L Balakrishnan3, Marjorie Gayanilo3, Chenni Sriram3, Sanjeev Aggarwal3.   

Abstract

The surgical options for significant aortic valve disease include either Ross procedure (RP) or aortic valve replacement (AVR). The exercise stress test is routinely performed in these patients to assess the objective functional capacity. This retrospective study was conducted to evaluate the differences and the longitudinal changes of exercise capacity in patients following the RP and AVR for aortic valve disease. This is an IRB approved retrospective study and included patients who had either RP or AVR performed for aortic valve disease and had at least one exercise stress test performed after the surgical procedure. Patients with other congenital heart disease, pacemaker or defibrillators, and those with inadequate data were excluded. Demographic data including age at surgery, type of surgery and type of aortic valve was collected. Data regarding treadmill cardiopulmonary exercise test (CPET) was also collected. A total of 47 patients met inclusion criteria and were equally represented in each group, i.e. RP [n = 23, 73.9% male, age at surgery 11.2 (4.5-15.9) years] vs. AVR [n = 24, 88% mechanical AVR, 60.9% male, age at surgery 15.1 (12.8-19.4) years]. There was a significant decline in predicted oxygen consumption (%VO2) at time of first post-operative CPET in patients after AVR compared to RP (79 vs. 88%, p = 0.048) over a similar accrued median interval follow-up (4.6 vs. 6.2 years, p = 0.2). The longitudinal follow-up analysis of following AVR (n = 11, 54.5% male, median inter-test duration of 5 years) showed significant decline in peak exercise capacity or VO2 (34.2 vs. 26.2 vs., p = 0.006). In contrast, after RP (n = 12 patients [58.3% male, median inter-test duration 7.1 of years], exercise capacity and other key parameters remained preserved. In this small sentinel study, we report a better initial exercise capacity among patients after RP compared to AVR over an intermediate follow-up. During longitudinal follow-up in a subset of patients, exercise capacity remained preserved amongst the RP group while it further declined in the AVR group.

Entities:  

Keywords:  Aortic valve replacement; Exercise capacity; Prosthesis-patient mismatch; Ross procedure

Year:  2021        PMID: 33682063     DOI: 10.1007/s00246-021-02575-4

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  15 in total

1.  Usefulness of the indexed effective orifice area at rest in predicting an increase in gradient during maximum exercise in patients with a bioprosthesis in the aortic valve position.

Authors:  P Pibarot; J G Dumesnil; J Jobin; M Lemieux; G Honos; L G Durand
Journal:  Am J Cardiol       Date:  1999-02-15       Impact factor: 2.778

2.  Clinical stress testing in the pediatric age group: a statement from the American Heart Association Council on Cardiovascular Disease in the Young, Committee on Atherosclerosis, Hypertension, and Obesity in Youth.

Authors:  Stephen M Paridon; Bruce S Alpert; Steven R Boas; Marco E Cabrera; Laura L Caldarera; Stephen R Daniels; Thomas R Kimball; Timothy K Knilans; Patricia A Nixon; Jonathan Rhodes; Angela T Yetman
Journal:  Circulation       Date:  2006-03-27       Impact factor: 29.690

3.  Ross Procedure vs Mechanical Aortic Valve Replacement in Adults: A Systematic Review and Meta-analysis.

Authors:  Amine Mazine; Rodolfo V Rocha; Ismail El-Hamamsy; Maral Ouzounian; Bobby Yanagawa; Deepak L Bhatt; Subodh Verma; Jan O Friedrich
Journal:  JAMA Cardiol       Date:  2018-10-01       Impact factor: 14.676

4.  A single-center experience with the ross procedure over 20 years.

Authors:  Martin Andreas; Gernot Seebacher; Eric Reida; Dominik Wiedemann; Christiane Pees; Raphael Rosenhek; Georg Heinze; Anton Moritz; Alfred Kocher; Guenther Laufer
Journal:  Ann Thorac Surg       Date:  2013-10-08       Impact factor: 4.330

5.  Exercise stress echocardiography after childhood Ross surgery: functional outcome in 26 patients from a single institution.

Authors:  Linda B Pauliks; J Brian Clark; Ashley Rogerson; Amy DiPietro; John L Myers; Stephen E Cyran
Journal:  Pediatr Cardiol       Date:  2012-02-21       Impact factor: 1.655

6.  Exercise performance in children and adolescents after the Ross procedure.

Authors:  Bradley S Marino; Sara K Pasquali; Gil Wernovsky; John R Bockoven; Michael McBride; Catherine J Cho; Thomas L Spray; Stephen M Paridon
Journal:  Cardiol Young       Date:  2006-02       Impact factor: 1.093

7.  Aortic valve prosthesis-patient mismatch and exercise capacity in adult patients with congenital heart disease.

Authors:  Ymkje J van Slooten; Joost P van Melle; Hendrik G Freling; Berto J Bouma; Arie Pj van Dijk; Monique Rm Jongbloed; Martijn C Post; Gertjan T Sieswerda; Anna Huis In 't Veld; Tjark Ebels; Adriaan A Voors; Petronella G Pieper
Journal:  Heart       Date:  2015-11-23       Impact factor: 5.994

8.  Functional outcomes after the Ross (pulmonary autograft) procedure assessed with magnetic resonance imaging and cardiopulmonary exercise testing.

Authors:  Rajesh Puranik; Victor T Tsang; Andrew Broadley; Johannes Nordmeyer; Phillip Lurz; Nagarajan Muthialu; Graham Derrick; Fiona Walker; Seamus Cullen; Marc de Leval; Phillip Bonhoeffer; Andrew M Taylor; Vivek Muthurangu
Journal:  Heart       Date:  2009-06-18       Impact factor: 5.994

9.  Ross Versus Non-Ross Aortic Valve Replacement in Children: A 22-Year Single Institution Comparison of Outcomes.

Authors:  John W Brown; Parth M Patel; Jiuann-Huey Ivy Lin; Asma S Habib; Mark D Rodefeld; Mark W Turrentine
Journal:  Ann Thorac Surg       Date:  2016-04-01       Impact factor: 4.330

10.  Decreased aerobic capacity 4 years after aortic valve replacement in male patients operated upon for chronic aortic regurgitation.

Authors:  Kristofer Hedman; Éva Tamás; Eva Nylander
Journal:  Clin Physiol Funct Imaging       Date:  2011-12-02       Impact factor: 2.273

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.